Use of Longitudinal Dose–Response Modeling to Support the Efficacy and Tolerability of Alitretinoin in Severe Refractory Chronic Hand Eczema (CHE)

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|4|4|255-262

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.4, 2015-04, pp. : 255-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alitretinoin: In Severe Chronic Hand Eczema

By Garnock-Jones Karly P.   Perry Caroline M.  

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1625-1634

Adis International

Access to resources Recommend Favorite

Alitretinoin: a guide to its use in severe chronic hand eczema

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 4, 2010-04 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal

By Rodgers Mark  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 351-362

Adis International

Access to resources Recommend Favorite

Alitretinoin [Toctino; Basilea Pharmaceutica] has been accepted as a treatment for severe chronic hand eczema in Scotland's NHS

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 574, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Analgesic Efficacy and Tolerability of Tramadol 100mg Sustained-Release Capsules in Patients with Moderate to Severe Chronic Low Back Pain

By Raber M.  

Clinical Drug Investigation, Vol. 17, Iss. 6, 1999-06 ,pp. : 415-423

Adis International

Access to resources Recommend Favorite